CMS Open Payments · Program Year 2024
Uswm, LLC
Uswm, LLC reported $365,142.06 across General Payments, Research, and Ownership to 899 physicians and teaching hospitals across 903 transactions.
- $365.1K Above-median payer
- All-tracks total
- 903 Above-median volume
- Transactions
- 899 Above-median reach
- Recipients
- −$991.6K
- General Payments vs PY2023
Uswm, LLC reported $365,142.06 across all CMS Open Payments tracks (General + Research + Ownership) to 899 physicians and teaching hospitals in Program Year 2024 - ranking #851 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $57,761.26, averaging $406.16 per recipient.
How Uswm, LLC's $365.1K all-tracks total breaks down
Uswm, LLC's payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
28/100
Total payments
F
13/100
Transaction volume
F
17/100
Physician reach
F
17/100
Payment type diversity
D
63/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer uswm-llc Uswm, LLC
$365.1K · #851/1,925 · 0.0% industry · PY2024
- TOT $365.1K
- RANK #851
- SHARE 0.0%
- TXN 903
- RCP 899
- CAT 5
- GEN $57.8K
- ΔGEN −$991.6K
- TOP1 22.3%
- PY 2024
Volume peers
Nearest volume peer: Heidelberg Engineering, Inc. ($361.5K)
Uswm, LLC sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Uswm, LLC's CMS-reported General Payments decreased by $991.6K (−94.5%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: USWM, LLCPY2023: USWM, LLCPY2024: USWM, LLC. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $1,049,348.56
- PY2024
- $57,761.26
What the Data Shows for Uswm, LLC
Three separate CMS disclosure tracks feed the all-tracks total above - General, Research, and Ownership/Investment - each reported under its own rules and combined here for one comparable figure. For Uswm, LLC, that total blends General Payments (day-to-day consulting, meals, travel and speaking fees, shown separately above) with Research and Ownership/Investment interest records, each governed by its own CMS reporting rules. CMS releases each Program Year roughly 12 months after it ends; the methodology page covers the full standardization basis.
The 5-category breakdown below covers general payments only (see our methodology for how research and ownership payments are reported separately). The largest general-payment category is "Food and Beverage" at $26.3K, accounting for 45.5% of this company's General Payments and 879 transactions.
General Payment Breakdown by Type
Uswm, LLC made 5 types of general payments. "Food and Beverage" is the largest category at $26.3K, 45.5% of General Payments.
Uswm, LLC reports 5 general-payment categories - the top three are Food and Beverage (45.5%), Honoraria (25.9%), and Compensation for Services Other Than Consulting (19.3%). The remaining 2 categories make up 9.3% of this company's reported general-payment total. That multi-category mix is the kind of profile single-category reporters cannot show.
How Uswm, LLC divides its payments
How the reported total splits across payment categories
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Food and Beverage | $26.3K | 879 | 45.5% |
| Honoraria | $15.0K | 4 | 25.9% |
| Compensation for Services Other Than Consulting | $11.1K | 5 | 19.3% |
| Consulting Fee | $3.6K | 6 | 6.2% |
| Travel and Lodging | $1.8K | 5 | 3.1% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $29,085.40 (50.4%) of $57,761.26 in this company's General Payments records across 607 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Uswm, LLC
The five named recipients with the highest reported General Payments from this company
- 1
Giselle Saulnier Sholler
$12,854.67 across 12 reported transactions
- 2
Jacqueline Kraveka
$7,003.63 across 11 reported transactions
- 3
William Ferguson
$3,247.10 across 3 reported transactions
- 4
Nationwide Childrens Hospital
$3,000.00 across 1 reported transactions
- 5
Don Eslin
$2,980.00 across 2 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Uswm, LLC ranks #851 of 1,925 by total payments (top 44% by spend) but spreads that money notably more broadly than its spend rank alone would suggest -- #1,155 of 1,838 by HHI (bottom 37% least concentrated), a wider distribution than most similarly sized payers.
View all 12 companies in this HHI neighborhood as a list
- Barco, Inc. : $175.3K total payments, HHI 752
- Urogen Pharma, Inc. : $1.6M total payments, HHI 751
- CapsoVision, Inc. : $966.0K total payments, HHI 748
- Novo Nordisk Health Care AG : $442.0K total payments, HHI 746
- McKesson Medical-Surgical Minnesota Supply, Inc : $837.57 total payments, HHI 746
- CTL Medical Corporation : $565.3K total payments, HHI 745
- Uswm, LLC (this company) : $57.8K total payments, HHI 743
- Tokuyama Dental America Inc. : $79.2K total payments, HHI 733
- Samsung Bioepis Co., Ltd. : $85.2K total payments, HHI 728
- PharmaEssentia USA Corporation : $714.5K total payments, HHI 727
- Exactech, Inc. : $8.1M total payments, HHI 722
- Guerbet LLC : $589.2K total payments, HHI 722
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Uswm, LLC's, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Uswm, LLC.
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Uswm, LLC.
Showing 6 of 1,924 companies with CMS-reported payment data.
Maillefer Instruments Holding Sarl
Trice Medical, Inc.
Ossio Inc
Gamida Cell Inc.
Genmab BV
Put this to use
Uswm, LLC ranks #851 of 1,925 by all-tracks total payments, led by "Food and Beverage".
- See how manufacturer spending compares across the full leaderboard. Top 100 by total payments
- Compare "Food and Beverage" spend across every manufacturer, not just Uswm, LLC. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.